Small Molecule Development & Manufacturting at Quotient Sciences

Live Webinar: Improve Drug Solubility from Formulation to Scale-Up

8 September 2024
Overview

Join Robert Cornog (Senior Director, Product Development, Quotient Sciences) and Andrew Parker, PhD (Executive Drug Development Consultant, Quotient Sciences) to learn how a connected development strategy can help address drug solubility challenges from formulation selection through scale-up.

The webinar will explore approaches including hot melt extrusion, spray-dried dispersions, lipid-based formulations and particle size reduction, while highlighting how early formulation decisions can reduce downstream development and manufacturing risks.

What You Will Learn

Attendees will gain insights into:

  • How to assess poorly soluble molecules and develop a fit-for-purpose formulation strategy aligned with clinical objectives
  • Key considerations for selecting between HME, spray drying, lipid-based and particle size reduction approaches
  • ASD Science and challenges for developing stable ASDs
  • How to reduce scale-up and technology transfer risks through early formulation and manufacturing planning
  • The value of integrating formulation development, manufacturing and clinical testing to accelerate decision-making and development timelines

Register free on the Xtalks website

 

 

Register
Register now
Times

Tuesday, September 08, 2026

10am EDT  / 3pm BST  / 4pm CEST 

Meet our speakers:

Robert Cornog

Senior Director, Product Development

Robert Cornog has over 26 years of experience in product development and process design. Across a broad range of dosage forms and ...

About Robert
Dr. Andrew Parker

Executive Drug Development Consultant

Dr. Andrew Parker has over two decades of experience in the pharmaceutical industry, spanning from preclinical development, throug...

About Andrew